Invion (AU:IVX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Invion Limited has issued 588,236 new shares at $0.17 each, as it continues discussions with RMW Cho Group to potentially expand its Photosoft™ technology rights. This technology is part of Invion’s innovative approach to cancer treatment, using photodynamic therapy as a non-invasive alternative to traditional methods. The company remains a key player in the life sciences sector, with its shares actively traded on the ASX.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.